Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-28 @ 12:49 PM
Study NCT ID:
NCT03427866
Status:
COMPLETED
Last Update Posted:
2025-07-29
First Post:
2018-02-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ruxolitinib Pre-, During- and Post-HSCT for Patients With Primary or Secondary Myelofibrosis.
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-05-19
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-02
First Submit QC Date:
None
Study First Post Date:
2018-02-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-25
Last Update Post Date:
2025-07-29
Last Update Post Date Type:
ACTUAL